Professor Hany Ariffin  is  Professor of Paediatrics and Head of the Division of Paediatric Haematology-Oncology and Blood & Marrow Transplantation at the University of Malaya Medical Centre (UMMC). She also heads the Biobank Unit in the Faculty of Medicine, UM.  Her main research interest is childhood leukaemia and she has been the Malaysian lead for the Malaysia-Singapore (MASPORE) Leukaemia Study Group since 2003. Her other research areas include childhood cancer survivorship, stem cell transplantation and inherited cancers, particularly related to mutations in the tumour suppressor gene, TP53. In 2015, she won the Anugerah Akademik Negara award and in 2018 received the Distinguished Researcher Award from University Malaya. Professor Hany is chairperson of the paediatric oncology accreditation committee for the National Specialist Register and a past president of the Malaysian Society of Paediatric Haematology-Oncology. She is also the chairperson of the VIVA-Asia Bone Marrow Transplantation Consortium for 2023/2024.  As co-chair of the Asian Childhood Cancer Alliance, Professor Hany works with regional colleagues as well as StJude Children's Research Hospital  to support the WHO Global Initiative for Childhood Cancer (WHO-GICC). The project's tagline is: “60 by 30” - which refers to the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives around the world.  Professor Hany has been a reviewer for many scientific journals and is currently an Associate Editor (Tumour Biology) for Technology in Cancer Reseach &Treatment.     

Dr. Nurzatil Sharleeza is a senior lecturer at Department of Science and Technology Studies, Faculty of Science, Universiti Malaya. She obtained her Bachelor and Doctoral degrees in the field of Biotechnology from The University of Queensland, Australia. During her studies, she received multiple research scholarships, including University of Queensland Summer Research Scholarship (2009/2010) and (2010/2011), and UQ IMB Undergraduate Research Award (2010), and was selected as a member of Advanced Studies Program in Science (ASPinS) - which is a highly selective program for UQ undergraduates. Earning these awards gave Dr Nurzatil an opportunity to involve in multidisciplinary research projects related to membrane-targetting vancomycin and carbapenem derivatives tagged with short peptides and lipophilic elements, photosensitisers for cancer imaging and nanopolymers for siRNA delivery.Due to her passion in technology commercialization, she pursued Doctor of Biotechnology and secured an internship position at UniQuest (Australia) and IBD (Malaysia). She then was offered a position as a postdoctoral research fellow at CEBAR UM for 2.5 years and then she worked at the Academy of Sciences Malaysia as a project manager for the Malaysia Open Science Platform (MOSP). Although no longer managing the Project, Dr Nurzatil is still attached to Open Science as an ex-officio member of MOSP Alliance, and a member of UM Open Science Steering Committee and the UM Open Science Coordinator. Dr Nurzatil was a member of Global Young Academies Working Group on Open Science, and led the FAIR Data Stewardship Guidelines for Reproducibility in Biodiversity Research project. Currently, she is a member of International Data Policy Committee (IDPC) CODATA and a member of OPEN ASIA ERASMUS+ project.  Dr Nurzatil's research interests include social and governance of emerging technology, food systems, and Responsible Research Innovation.  

Dr. Woo is a consultant gynaecological oncologist with clinical and research experience that ranges from prevention to treatment of cervical cancer and hereditary/ familial gynaecological cancers. She undertook her research in HPV immune-biology in the University of Cambridge under the Cancer Research UK Gordon Hamilton Fairley Fellowship and was awarded a PhD degree in 2008. As a clinician, she was awarded the gold medal by the Royal College of Obstetrician and Gynaecologist as the top ranked individual for the international examination. Having trained and worked in the UK, she returned to Malaysia in 2010 to take up a professorial post in the premier teaching hospital, University Malaya (UM). As a translational scientist, she has worked tirelessly to making this knowledge more accessible and applicable to the broader population through her advisory role on policy development nationally and internationally. She is also a recognized expert in HPV vaccination and is currently the country representative (Malaysia) for the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN), taskforce member for the Malaysian policy change to Primary HPV screening for cervical cancer, member of the Asia Pacific Economic Consortium (APEC) Cervical Cancer working group and is the founding principal investigator for Program ROSE (Removing Obstacles to cervical ScrEening, a revolutionary approach to cervical cancer screening. Program ROSE (www.programrose.org, @programROSE) that utilizes digital technology, self-sampling and HPV testing. The program was recently highlighted by the Economist Intelligence Unit (https://eiuperspectives.economist.com/healthcare/global-action-financing-cervical-cancer-elimination-funding-secondary-prevention-services-low). The program was a strong contender at the 2018 UICC Collaborative award, shortlisted among 2 other nominations globally, and has received many international accolades and praises. Program ROSE (www.programrose.org, @programROSE) utilizes digital technology, self-sampling and HPV testing to change the paradigm of conventional cervical screening, facilitating increased screening uptake for ALL woman. Dr Woo is also the founder of ROSE Foundation, a non-profit organisation, dedicated to making cervical cancer prevention accessible and affordable to the underprivileged. The success of Program ROSE is a testament to her incessant drive to make cervical cancer a rare disease in our lifetime. She also dedicates her time to working closely with other academic institutions, NGOS and also industry to educate, inform and advise on matters pertaining to control of HPV associated diseases. In recognition for her contribution to women's health, Dr. Woo was conferred the FIGO Awards in recognition of Female Obstetrician and Gynaecologist in 2021.